Bioceres Crop Solutions Corp. to Post FY2022 Earnings of $0.01 Per Share, Zacks Small Cap Forecasts (NYSEMKT:BIOX)

Bioceres Crop Solutions Corp. (NYSEMKT:BIOXGet Rating) – Zacks Small Cap decreased their FY2022 earnings estimates for shares of Bioceres Crop Solutions in a report issued on Thursday, June 16th. Zacks Small Cap analyst S. Ralston now expects that the company will post earnings per share of $0.01 for the year, down from their previous estimate of $0.17. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.05 per share.

BIOX stock opened at $12.15 on Monday. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.68 and a current ratio of 1.16. The firm has a market capitalization of $499.37 million, a PE ratio of -303.75 and a beta of 0.55. The stock’s 50 day moving average is $13.37 and its 200 day moving average is $13.36.

Institutional investors have recently made changes to their positions in the business. BlackRock Inc. lifted its position in Bioceres Crop Solutions by 38.6% during the 1st quarter. BlackRock Inc. now owns 119,484 shares of the company’s stock valued at $1,627,000 after purchasing an additional 33,253 shares during the period. The Manufacturers Life Insurance Company boosted its holdings in shares of Bioceres Crop Solutions by 13.2% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 36,846 shares of the company’s stock valued at $497,000 after buying an additional 4,294 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Bioceres Crop Solutions in the 4th quarter valued at approximately $366,000. Geode Capital Management LLC boosted its holdings in shares of Bioceres Crop Solutions by 3.7% in the 3rd quarter. Geode Capital Management LLC now owns 21,277 shares of the company’s stock valued at $287,000 after buying an additional 755 shares during the last quarter. Finally, Marshall Wace LLP acquired a new stake in shares of Bioceres Crop Solutions in the 4th quarter valued at approximately $125,000. 1.87% of the stock is currently owned by hedge funds and other institutional investors.

Bioceres Crop Solutions Company Profile (Get Rating)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments.

See Also

Want More Great Investing Ideas?

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.